Market Wrap | S&P 500 Dow Jones Nasdaq Drop Fed Rate Cut Concerns

On May 28, 2025, the S&P 500 Index fell by 0.56%, the Dow Jones Industrial Average dropped by 0.58%, and the Nasdaq Composite Index declined by 0.51%. The Federal Reserve minutes suggest potential rate cuts by year-end due to increased downside risks in policy rate expectations. Additionally, there is concern that U.S. assets losing their "safe haven" status due to global trade tensions may have long-term economic impacts.

In today's market, several sectors underperformed the S&P 500, including utilities, energy, materials, financials, and consumer staples. Conversely, the communication services and real estate sectors bucked the trend and saw gains.

Spero Therapeutics saw a remarkable surge of 244.57% today, driven by the positive Phase 3 trial results for tebipenem HBr. This breakthrough has significantly boosted investor confidence in the company's prospects. Aspire Biopharma also experienced a substantial rise of 197.43%, attributed to its innovative sublingual nano technology, which offers disruptive benefits to the pre-workout market. On the other hand, InflaRx faced a dramatic decline of 59.86% following the decision to halt trials of its lead drug, vilobelimab. This setback has raised concerns among investors about the company's future developments. Patriot National Bancorp dropped 51.02%, with few to no technical positive signals and multiple sell signals for its stock.

请提供新闻内容以便我进行筛选和总结。